Clinical Trial Update: Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating silymarin in hospitalized COVID-19 patients with elevated liver enzymes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Diseases

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | Conditions: Covid19, Liver Diseases | Phase 4 | Status: COMPLETED